Sinovac Biotech (SVA) Current Assets (2009 - 2026)
Sinovac Biotech (SVA) posted Current Assets of $6.62 billion for Q2 2026, down 36.2% from $10.38 billion a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Sinovac Biotech's Current Assets came in at $7.06 billion, down 33.6% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 35.3% (FY2020 to FY2025).
- In prior years, Sinovac Biotech's Current Assets was $10.64 billion in FY2024 (-8.2%), $11.6 billion in FY2023 (+2.6%), $11.3 billion in FY2022 (-24.3%) and $14.94 billion in FY2021 (+857.4%).
- The Q2 2026 figure stands as the lowest quarterly Current Assets since Q4 2020.
- The strongest year-over-year quarter for Current Assets in the past five years was Q4 2021, with growth of 857.4%; the weakest was Q2 2026, with a decline of 36.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | 6.62 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.62 Bn |
| Dec 31, 2025 | 7.06 Bn |
| Jun 30, 2025 | 10.38 Bn |
| Dec 31, 2024 | 10.64 Bn |
| Jun 30, 2024 | 11.15 Bn |
| Dec 31, 2023 | 11.60 Bn |
| Jun 30, 2023 | 11.77 Bn |
| Dec 31, 2022 | 11.30 Bn |
| Jun 30, 2022 | 13.12 Bn |
| Dec 31, 2021 | 14.94 Bn |
| Jun 30, 2021 | 11.69 Bn |
| Dec 31, 2020 | 1.56 Bn |
| Sep 30, 2020 | 424.77 Mn |
| Jun 30, 2020 | 338.00 Mn |
| Mar 31, 2020 | 329.35 Mn |
| Dec 31, 2019 | 349.61 Mn |
| Sep 30, 2019 | 313.36 Mn |
| Jun 30, 2019 | 303.79 Mn |
| Mar 31, 2019 | 283.22 Mn |
| Dec 31, 2018 | 284.18 Mn |
API Access
Sinovac Biotech Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();